Search

Khurana, Specht, AH Beggs, Tomé, Letureq, Chevallay, Chafey, and Kunkel. 1997. “The Concomitant Use of Dystrophin and Utrophin/Dystrophin Related Protein Antibodies to Reduce Misdiagnosis of Duchenne/Becker Muscular Dystrophy.”. Biochem Biophys Res Commun 241 (2): 232-5.

Scharf, Damron, Frisella, Bruno, AH Beggs, Kunkel, and Dietrich. 1996. “The Mouse Region Syntenic for Human Spinal Muscular Atrophy Lies Within the Lgn1 Critical Interval and Contains Multiple Copies of Naip Exon 5.”. Genomics 38 (3): 405-17.

North, Specht, Sethi, Shapiro, and AH Beggs. 1996. “Congenital Muscular Dystrophy Associated With Merosin Deficiency.”. J Child Neurol 11 (4): 291-5.

Zhu, Guo, AH Beggs, Maruyama, Santarius, Dashner, Olsen, Wu, and Black. 1996. “Microsatellite Instability Analysis of Primary Human Brain Tumors.”. Oncogene 12 (7): 1417-23.

Zhu, Frosch, Busque, AH Beggs, Dashner, Gilliland, and Black. 1995. “Analysis of Meningiomas by Methylation- and Transcription-Based Clonality Assays.”. Cancer Res 55 (17): 3865-72.

Passos-Bueno, Byth, Rosenberg, Takata, Bakker, AH Beggs, Pavanello, Vainzof, Davies, and Zatz. 1993. “Severe Nonspecific X-Linked Mental Retardation Caused by a Proximally Xp Located Gene: Intragenic Heterogeneity or a New Form of X-Linked Mental Retardation?”. Am J Med Genet 46 (2): 172-5.

Beggs, AH, Miner, and Scangos. 1990. “Cell Type-Specific Expression of JC Virus T Antigen in Primary and Established Cell Lines from Transgenic Mice.”. J Gen Virol 71 ( Pt 1): 151-64.

Koenig, AH Beggs, Moyer, Scherpf, Heindrich, Bettecken, Meng, Müller, Lindlöf, and Kaariainen. 1989. “The Molecular Basis for Duchenne versus Becker Muscular Dystrophy: Correlation of Severity With Type of Deletion.”. Am J Hum Genet 45 (4): 498-506.

Beggs, AH, and Scangos. 1986. “Serum-Free Selection of Onc Genes.”. Gene Amplif Anal 4: 177-95.

Brownstein, Catherine, Alan Beggs, Nils Homer, Barry Merriman, Timothy Yu, Katherine Flannery, Elizabeth Dechene, et al. 2014. “An International Effort towards Developing Standards for Best Practices in Analysis, Interpretation and Reporting of Clinical Genome Sequencing Results in the CLARITY Challenge.”. Genome Biol 15 (3): R53.